6-Quinoxalinamine, 5-bromo-N-1H-imidazol-2-yl-(151110-15-5)
- Name: 6-Quinoxalinamine, 5-bromo-N-1H-imidazol-2-yl-
- Synonyms:151110-15-5;4,5-Didehydro Brimonidine;5-bromo-N-(1H-imidazol-2-yl)quinoxalin-6-amine;6-Quinoxalinamine, 5-bromo-N-1H-imidazol-2-yl-;FZ344QNP7Y;UNII-FZ344QNP7Y;CHEMBL1019;5-Bromo-N-1H-imidazol-2-yl-6-quinoxalinamine;Brimonidine tartrate impurity F [EP];Brimonidine EP Impurity F;SCHEMBL7803704;BDBM50055828;(5-Bromo-quinoxalin-6-yl)-(1H-imidazol-2-yl)-amine;BRIMONIDINE TARTRATE IMPURITY F [EP IMPURITY];B0463-467714;J59
- Molecular Formula:C11H8BrN5
- Molecular Weight:290.12
- CAS Registry Number:151110-15-5
- EINECS:837-242-9
- Melting Point:
- Water Solubility:
CAS No.151110-15-5 Brimonidine Impurity F
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Transportation:express and sea transport and air freight Application:for drug impurity for drug standards,for drug research and development銆侱rug impurity reference, drug standard, analytical chemistry, standard substance, organic chemical synthesis, chemical custo...
Min. Order:25Milligram
Supplier:Hubei Moxin Biotechnology Co., Ltd [ China (Mainland)]
Premium
SupplierTel:+86-173-20513646
Address:Company address: Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China
- Contact Suppliers
CAS No.151110-15-5 Brimonidine Related Impurity 2
Assay:> 95% Package:inquiry Transportation:inquiry Application:Brimonidine Related Impurity 2 is a brimonidine impurity.
Min. Order:1Gram
Supplier:BOC Sciences [ United States]
Premium
SupplierTel:1-631-485-4226
Address:Ramsey Road
- Contact Suppliers
Other Product
- 479578-27-3/Folcepri
- 210346-39-7/8-Amino-6-fluoro-5-methyl-3,4-dihydronaphthalen-1(2H)-one
- 51438-95-0/2-Naphthalenol, 5,6,7,8-tetrahydro-5,5-dimethyl-
- 1199773-26-6/4-(4-Bromo-1H-pyrazol-1-yl)-N,N-dimethylbenzenesulfonamide
- 51282-41-8/4-Benzoyl-2-methylisoquinolin-2-ium hexafluoridophosphate(1-)
- 1260387-16-3/4-Methoxypiperidine-4-carboxylic acid hydrochloride
- 1800070-34-1/2-(Methoxymethyl)-1-methyl-3-nitrobenzene
- 2055024-65-0/Azido-PEG3-Val-Cit-PAB-OH
- 2006278-31-3/2-(5-Bromo-4-fluoro-2-methoxyphenyl)-4-pentyn-2-ol
- 1174064-68-6/tert-butyl (S)-4-(dimethylamino)-1-(piperazine-1-carbonyl)butylcarbamate
- 898783-92-1/2-(3-Bromophenyl)-4'-iodoacetophenone
- 479642-48-3/Tbsct-fp
- 1220031-90-2/4-[2-(3-Isopropylphenoxy)ethyl]piperidine hydrochloride
- 914637-97-1/5-Bromo-2-cyanonicotinic acid
- 1452575-88-0/L-Proline, 1-[(3,5-dimethyl-4-isoxazolyl)methyl]-
- 148252-40-8/2-Bromo-3-(4-cyanophenyl)-1-propene
- 1256467-37-4/2,2,2-Trifluoro-1-(5-fluoro-2-methoxyphenyl)ethanone
- 1427475-27-1/Methyl 4-(Cbz-amino)tetrahydropyran-4-carboxylate
- 1883347-28-1/1-(5-Bromopyridin-3-yl)-2,2,2-trifluoroethanone hydrochloride
- 151110-15-5/6-Quinoxalinamine, 5-bromo-N-1H-imidazol-2-yl-
- 1363378-22-6/(3R,4S)-4-Amino-1-boc-3-methoxypiperidine
- 173860-22-5/(1-Acetamidoethyl)boronic acid
- 1159813-44-1/(5-Methyl-4,5-dihydro-1h-imidazol-4-yl)methanol hydrochloride
- 892691-05-3/2-Oxo-2-(2-phenylindolizin-3-yl)acetic acid
- 959241-67-9/2-[(3-Methylbenzyl)thio]ethanol
- 159871-54-2/tert-Butyl a-amino-cyclopropaneacetate
- 1211644-44-8/4,7-Dibromo-3-chloro-6-methylquinoline
- 898780-08-0/3-(3,5-Dimethylphenyl)-3'-methylpropiophenone
- 1809010-50-1/Orladeyo
- 197227-39-7/3,3',4,4'-Tetrahydroxy-2-methoxychalcone